Mehrnouch Motamedi

Statistics

Publications

Citations

172

H-Index

Active since

2003

Affiliations

Ligand Pharmaceuticals (United States)(Current)

Mehrnouch Motamedi is an author at Ligand Pharmaceuticals (United States) specializing in gonadal steroid hormones, drug discovery, and hormone receptors.

Publications per year

2003–2006

Publications

Discovery of 6-N,N-Bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a Novel Selective Androgen Receptor Modulator

Arjan van Oeveren, Mehrnouch Motamedi, Neelakandha S. Mani et al. · Journal of Medicinal Chemistry · 2006 · 79 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

5-Benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as Selective Progesterone Receptor Modulators

Christopher M. Tegley, Barbara Pio, James P. Edwards et al. · Journal of Medicinal Chemistry · 2003 · 64 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore

Josef D. Ringgenberg, James P. Edwards, Christopher M. Tegley et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 29 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

1–3 of 3